SIC
MED icon

SJS Investment Consulting’s Medifast MED Stock Holding History

SJS Investment Consulting’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287 Buy
27
+6
+29% +$69 ﹤0.01% 2410
2026
Q1 		$214 Buy
+21
New +$226 ﹤0.01% 1968
2023
Q3 		– Sell
-2
Closed -$185 – 1641
2023
Q2 		$185 Buy
+2
New +$178 ﹤0.01% 1420
2023
Q1 		– Sell
-2
Closed -$231 – 1611
2022
Q4 		$231 Buy
2
+1
+100% +$116 ﹤0.01% 1389
2022
Q3 		$0 Buy
+1
New +$143 ﹤0.01% 1331

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
CC
Commons Capital Needham, Massachusetts $143M AUM 30.09% 1-Year Est. Return
VFO
Virtus Family Office El Paso, Texas $126M AUM 23.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

SJS Investment Consulting's MED Position: Q2 2026 in Review

SJS Investment Consulting increased its Medifast (MED) stake by 29% in Q2 2026, buying an estimated $69 and bringing the position to 27 shares worth $287. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

SJS Investment Consulting first reported a position in MED in Q3 2022 and has held it in 5 quarters since. 43 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • SJS Investment Consulting held 27 shares of Medifast worth $287 as of Q2 2026.
  • SJS Investment Consulting bought 6 Medifast shares in Q2 2026, an estimated $69.
  • Medifast made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2410 holding.
  • SJS Investment Consulting first reported a position in Medifast in Q3 2022 and has held it in 5 quarters since.
  • 43 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.